CYCLERION THERAPEUTICS INC (CYCN) Stock Cash Flow
NASDAQ:CYCN - Nasdaq - US23255M2044 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 778.00K | -3.06M | -5.26M | -44.08M | -51.65M | |||
| Depreciation Amortization | N/A | N/A | 0.00 | 70.00K | 470.00K | |||
| Change In Working Capital | 3.41M | -1.54M | -4.60M | -2.85M | 1.41M | |||
| Other non cash items | 11.76M | 262.00K | -11.38M | 6.25M | 13.25M | |||
| OPERATING CASH FLOW | 15.94M | -4.33M | -21.25M | -40.61M | -36.52M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -10.00K | |||
| Other Investing Activity | N/A | 0.00 | 10.40M | 0.00 | 1.46M | |||
| INVESTING CASH FLOW | N/A | 0.00 | 10.40M | 0.00 | 1.46M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | -3.65M | 0.00 | 5.02M | 30.00K | 30.79M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -3.65M | 0.00 | 5.02M | 30.00K | 30.79M | |||
| Exchange Rate Effect | -14.00K | -6.00K | 8.00K | 0.00 | 0.00 | |||
| CHANGE IN CASH | 1.88M | -4.34M | -5.81M | -40.58M | -4.27M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 15.94M | -4.33M | -21.25M | -40.61M | -36.52M | |||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -10.00K | |||
| FREE CASH FLOW | 15.94M | -4.33M | -21.25M | -40.61M | -36.53M | |||
All data in USD